Myoglobin (3A7) Monoclonal Antibody, APC-Cy7 Conjugated

Référence bsm-41107M-APC-Cy7

Conditionnement : 100ul

Marque : Bioss

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

Myoglobin (3A7) Monoclonal Antibody, APC-Cy7 Conjugated

Applications

  • IF(IHC-P)
  • IF(ICC)

Reactivity

  • Human
  • Rat
Overview
Catalog # bsm-41107M-APC-Cy7
Product Name Myoglobin (3A7) Monoclonal Antibody, APC-Cy7 Conjugated
Applications IF(IHC-P), IF(ICC)
Reactivity Human, Rat
Specifications
Conjugation APC-Cy7
Host Mouse
Source Purified Human Myoglobin (Natural Human Myoglobin protein)
Clonality Monoclonal
Clone # 3A7
Isotype IgG
Concentration 1ug/ul
Purification Purified by Protein G.
Storage Buffer Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Target
Gene ID 4151
Swiss Prot P02144
Subcellular location Cytoplasm, Extracellular domain
Synonyms MYO; MB; MGC13548; PVALB; MYG_HUMAN.
Background Myoglobin is a small heme containing protein responsible for the oxygen deposition in muscle tissues. Only one form of myoglobin is expressed in cardiac and skeletal muscles. Myoglobin is known as a marker of myocardial damage and it has been used for more than three decades. Nowadays it still is very commonly used in clinical practice as an early marker of AMI. It appears in patient's blood 1 to 3 hours after onset of the symptoms, reaching peak level within 8 to 12 hours. Myoglobin is not so cardiac specific as cTnI or cTnT. Because of high myoglobin concentration in skeletal muscle tissue, even minor skeletal muscle injury results in the significant increase of myoglobin concentration in blood. Thus myoglobin is used together with cTnI or cTnT in clinical practise for better specificity in AMI diagnosis.
Application Dilution
IF(IHC-P) 1:50-200
IF(ICC) 1:50-200